Published in Thromb Haemost on December 01, 2000
HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol (2011) 6.23
New EMBO members' review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal. EMBO J (2001) 3.04
Human malarial disease: a consequence of inflammatory cytokine release. Malar J (2006) 2.36
The many faces of HMGB1: molecular structure-functional activity in inflammation, apoptosis, and chemotaxis. J Leukoc Biol (2013) 2.22
Pathogenesis of malaria and clinically similar conditions. Clin Microbiol Rev (2004) 1.87
High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease. Arthritis Res Ther (2008) 1.65
High mobility group protein-1 inhibits phagocytosis of apoptotic neutrophils through binding to phosphatidylserine. J Immunol (2008) 1.45
Role of HMGB1 in cardiovascular diseases. Curr Opin Pharmacol (2006) 1.26
The translocation of nuclear molecules during inflammation and cell death. Antioxid Redox Signal (2013) 0.96
Translational mini-review series on immunology of vascular disease: mechanisms of vascular inflammation and remodelling in systemic vasculitis. Clin Exp Immunol (2009) 0.95
High mobility group B1 protein interacts with its receptor RAGE in tumor cells but not in normal tissues. Oncol Lett (2011) 0.95
ADAMTS13 gene deletion enhances plasma high-mobility group box1 elevation and neuroinflammation in brain ischemia-reperfusion injury. Neurol Sci (2012) 0.92
Innate immunity, coagulation and placenta-related adverse pregnancy outcomes. Thromb Res (2009) 0.92
Platelet-derived HMGB1 is a critical mediator of thrombosis. J Clin Invest (2015) 0.91
Ménage à Trois in stress: DAMPs, redox and autophagy. Semin Cancer Biol (2013) 0.89
The expression of HMGB1 on microparticles released during cell activation and cell death in vitro and in vivo. Mol Med (2014) 0.87
Transfusion-Related Acute Lung Injury: The Work of DAMPs. Transfus Med Hemother (2013) 0.86
A high-sensitivity method for detection and measurement of HMGB1 protein concentration by high-affinity binding to DNA hemicatenanes. PLoS One (2008) 0.85
Platelet transfusion - the new immunology of an old therapy. Front Immunol (2015) 0.84
Stimulation of erythroleukaemia cell differentiation by extracellular high-mobility group-box protein 1 is independent of the receptor for advanced glycation end-products. Biochem J (2002) 0.84
HMGB1: a novel protein that induced platelets active and aggregation via Toll-like receptor-4, NF-κB and cGMP dependent mechanisms. Diagn Pathol (2015) 0.83
Platelets and Their Interactions with Other Immune Cells. Compr Physiol (2015) 0.83
High mobility group box 1 protein induction by Mycobacterium bovis BCG. Mediators Inflamm (2007) 0.81
The effects of smoking on levels of endothelial progenitor cells and microparticles in the blood of healthy volunteers. PLoS One (2014) 0.80
Staphylococcal toxic shock syndrome toxin-1 induces the translocation and secretion of high mobility group-1 protein from both activated T cells and monocytes. Mediators Inflamm (2008) 0.79
Vascular Remodelling and Mesenchymal Transition in Systemic Sclerosis. Stem Cells Int (2016) 0.78
Disruption of a Regulatory Network Consisting of Neutrophils and Platelets Fosters Persisting Inflammation in Rheumatic Diseases. Front Immunol (2016) 0.77
Regulation of Posttranslational Modifications of HMGB1 During Immune Responses. Antioxid Redox Signal (2016) 0.77
Platelets: New Bricks in the Building of Neutrophil Extracellular Traps. Front Immunol (2016) 0.76
Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice. Blood (2016) 0.76
Intercellular Interactions as Regulators of NETosis. Front Immunol (2016) 0.75
Platelet-derived high-mobility group box 1 promotes recruitment and suppresses apoptosis of monocytes. Biochem Biophys Res Commun (2016) 0.75
Increased platelet mitochondrial respiration after cardiac arrest and resuscitation as a potential peripheral biosignature of cerebral bioenergetic dysfunction. J Bioenerg Biomembr (2016) 0.75
Pivotal neuroinflammatory and therapeutic role of high mobility group box 1 in ischemic stroke. Biosci Rep (2017) 0.75
Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell (2001) 15.05
Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science (1997) 6.37
Regulation of cell fate decision of undifferentiated spermatogonia by GDNF. Science (2000) 5.44
Serotypes, hemolysin production, and receptor recognition of Escherichia coli strains associated with neonatal sepsis and meningitis. Infect Immun (1985) 4.01
Escherichia coli fimbriae recognizing sialyl galactosides. J Bacteriol (1984) 3.16
Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol Chem (1999) 3.12
Escherichia coli strains binding neuraminyl alpha 2-3 galactosides. Biochem Biophys Res Commun (1983) 2.87
Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J Biol Chem (2000) 2.78
Identification of the O-linked sialyloligosaccharides of glycophorin A as the erythrocyte receptors for S-fimbriated Escherichia coli. Infect Immun (1986) 2.62
Expression of glucocorticoid receptor beta in lymphocytes of patients with glucocorticoid-resistant ulcerative colitis. Gastroenterology (2000) 2.08
Role of the tricuspid annulus and the eustachian valve/ridge on atrial flutter. Relevance to catheter ablation of the septal isthmus and a new technique for rapid identification of ablation success. Circulation (1996) 2.04
Association of cortactin with dynamic actin in lamellipodia and on endosomal vesicles. J Cell Sci (2000) 2.04
Image processing for the study of brain structure and function: problems and programs. J Neuropsychiatry Clin Neurosci (1992) 1.97
Abdominal ultrasonography for the diagnosis of strangulation in small bowel obstruction. Br J Surg (1994) 1.95
Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. Am J Pathol (2000) 1.93
Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet (1990) 1.88
The O75X adhesin of uropathogenic Escherichia coli is a type IV collagen-binding protein. Mol Microbiol (1989) 1.87
The structural basis of the different affinities of two types of acidic N-glycosidic glycopeptides for concanavalin A--sepharose. FEBS Lett (1976) 1.84
Strain and gender differences in the behavior of mouse lines commonly used in transgenic studies. Physiol Behav (2001) 1.81
Retinoids exacerbate rat liver fibrosis by inducing the activation of latent TGF-beta in liver stellate cells. Hepatology (1997) 1.74
Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease. Nature (1988) 1.71
Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells. Br J Cancer (1996) 1.70
Long-term individual housing in C57BL/6J and DBA/2 mice: assessment of behavioral consequences. Genes Brain Behav (2005) 1.70
Holter monitoring as a noninvasive indicator of cardiac involvement in sarcoidosis. Chest (1994) 1.69
Epstein-Barr virus infection of human gastric carcinoma cells: implication of the existence of a new virus receptor different from CD21. J Virol (1997) 1.69
Chromosome translocation and c-MYC activation by Epstein-Barr virus and Euphorbia tirucalli in B lymphocytes. Lancet (1991) 1.61
Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer. Cancer Res (1998) 1.59
Binding characteristics of Escherichia coli adhesins in human urinary bladder. Infect Immun (1988) 1.53
Studies on cell adhesion and recognition. I. Extent and specificity of cell adhesion triggered by carbohydrate-reactive proteins (glycosidases and lectins) and by fibronectin. J Cell Biol (1981) 1.52
Binding of Escherichia coli S fimbriae to human kidney epithelium. Infect Immun (1986) 1.46
Cortactin-Src kinase signaling pathway is involved in N-syndecan-dependent neurite outgrowth. J Biol Chem (1998) 1.46
30-kDa heparin-binding protein of brain (amphoterin) involved in neurite outgrowth. Amino acid sequence and localization in the filopodia of the advancing plasma membrane. J Biol Chem (1991) 1.46
Regulation of cell migration by amphoterin. J Cell Sci (2000) 1.41
Molecular cloning of a novel diacylglycerol kinase isozyme with a pleckstrin homology domain and a C-terminal tail similar to those of the EPH family of protein-tyrosine kinases. J Biol Chem (1996) 1.40
Transgenic expression of syndecan-1 uncovers a physiological control of feeding behavior by syndecan-3. Cell (2001) 1.40
Amphoterin, the 30-kDa protein in a family of HMG1-type polypeptides. Enhanced expression in transformed cells, leading edge localization, and interactions with plasminogen activation. J Biol Chem (1993) 1.40
Summary report on the ISOBM TD-4 Workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin. San Diego, Calif., November 17-23, 1996. Tumour Biol (1998) 1.40
[Effect of percutaneous transvenous mitral commissurotomy for the preservation of sinus rhythm in patients with mitral stenosis]. J Cardiol (2001) 1.39
Isolation of a neuronal cell surface receptor of heparin binding growth-associated molecule (HB-GAM). Identification as N-syndecan (syndecan-3). J Biol Chem (1994) 1.38
The relationship between perlecan and dystroglycan and its implication in the formation of the neuromuscular junction. Cell Adhes Commun (1998) 1.37
Interactions of plasminogen and tissue plasminogen activator (t-PA) with amphoterin. Enhancement of t-PA-catalyzed plasminogen activation by amphoterin. J Biol Chem (1991) 1.36
Novel fucolipids accumulating in human adenocarcinoma. III. A hybridoma antibody (FH6) defining a human cancer-associated difucoganglioside (VI3NeuAcV3III3Fuc2nLc6). J Biol Chem (1984) 1.35
Retarded growth and deficits in the enteric and parasympathetic nervous system in mice lacking GFR alpha2, a functional neurturin receptor. Neuron (1999) 1.35
Chaperone function of calreticulin when expressed in the endoplasmic reticulum as the membrane-anchored and soluble forms. J Biol Chem (1995) 1.35
Behavioral alterations induced by repeated testing in C57BL/6J and 129S2/Sv mice: implications for phenotyping screens. Genes Brain Behav (2004) 1.32
Inverse relationship between electrode size and lesion size during radiofrequency ablation with active electrode cooling. Circulation (1998) 1.31
Epstein-Barr virus lacking glycoprotein gp85 cannot infect B cells and epithelial cells. Virology (2000) 1.30
Tissue tropism of Escherichia coli adhesins in human extraintestinal infections. Curr Top Microbiol Immunol (1990) 1.30
Expression of the heparin-binding cytokines, midkine (MK) and HB-GAM (pleiotrophin) is associated with epithelial-mesenchymal interactions during fetal development and organogenesis. Development (1995) 1.30
Epstein-Barr virus and gastric carcinoma. Semin Cancer Biol (1996) 1.28
Transcriptional regulation of bialaphos biosynthesis in Streptomyces hygroscopicus. J Bacteriol (1987) 1.26
Actions of calcium and certain multivalent cations on potassium contracture of guinea-pig's taenia coli. J Physiol (1967) 1.25
Intervention of T-cells in transportation of mouse mammary tumor virus (milk factor) to mammary gland cells in vivo. Cancer Res (1988) 1.23
Studies on cell adhesion and recognition. II. The kinetics of cell adhesion and cell spreading on surfaces coated with carbohydrate-reactive proteins (glycosidases and lectins) and fibronectin. J Cell Biol (1981) 1.22
Molecular cloning of the 18-kDa growth-associated protein of developing brain. J Biol Chem (1990) 1.22
Heparin-binding proteins HB-GAM (pleiotrophin) and amphoterin in the regulation of cell motility. Matrix Biol (2000) 1.21
Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate. Br J Cancer (1999) 1.21
Amphoterin as an extracellular regulator of cell motility: from discovery to disease. J Intern Med (2004) 1.20
Studies on the biosynthesis of bialaphos (SF-1293). 6. Production of N-acetyl-demethylphosphinothricin and N-acetylbialaphos by blocked mutants of Streptomyces hygroscopicus SF-1293 and their roles in the biosynthesis of bialaphos. J Antibiot (Tokyo) (1985) 1.19
Synovial lining, endothelial and inflammatory mononuclear cell proliferation in synovial membranes in psoriatic and reactive arthritis: a comparative quantitative morphometric study. Br J Rheumatol (1998) 1.19
Activation of human umbilical vein endothelial cells leads to relocation and release of high-mobility group box chromosomal protein 1. Scand J Immunol (2004) 1.19
The poly(glycosyl) chains of glycoproteins. Characterisation of a novel type of glycoprotein saccharides from human erythrocyte membrane. Eur J Biochem (1978) 1.18
Detection of Epstein-Barr virus (EBV) in hepatocellular carcinoma tissue: a novel EBV latency characterized by the absence of EBV-encoded small RNA expression. Virology (1999) 1.17
Isolation and structural characterization of five major sialyloligosaccharides and a sialylglycopeptide from normal human urine. Eur J Biochem (1983) 1.13
Neurite growth-promoting protein (amphoterin, p30) binds syndecan. Exp Cell Res (1992) 1.13
Neurite outgrowth in brain neurons induced by heparin-binding growth-associated molecule (HB-GAM) depends on the specific interaction of HB-GAM with heparan sulfate at the cell surface. J Biol Chem (1996) 1.12
Studies on the biosynthesis of bialaphos (SF-1293) 12. C-P bond formation mechanism of bialaphos: discovery of a P-methylation enzyme. J Antibiot (Tokyo) (1992) 1.11
Cardiotoxic effects of 5-fluorouracil in the guinea pig. Jpn J Pharmacol (1980) 1.11
Promotion of transferrin folding by cyclic interactions with calnexin and calreticulin. EMBO J (1997) 1.10
Replacement of Streptomyces hygroscopicus genomic segments with in vitro altered DNA sequences. J Antibiot (Tokyo) (1988) 1.10
Role of interleukin-1beta and tumor necrosis factor-alpha-dependent expression of cyclooxygenase-2 mRNA in thermal hyperalgesia induced by chronic inflammation in mice. Neuroscience (2007) 1.10
Modification of viral myocarditis in mice by interleukin-6. Circ Res (1996) 1.10
Porcine 80-kDa diacylglycerol kinase is a calcium-binding and calcium/phospholipid-dependent enzyme and undergoes calcium-dependent translocation. J Biol Chem (1991) 1.10
Isolation and structural elucidation of an antioxidative agent, naphterpin. J Antibiot (Tokyo) (1990) 1.09
Structural similarity of the terminal carbohydrate sequences of glycoproteins and glycolipids. FEBS Lett (1979) 1.09
Effect of vasodilators upon the isolated taenia coli of the guinea pig. J Pharmacol Exp Ther (1967) 1.09
Studies on the biosynthesis of bialaphos (SF-1293). 2. Isolation of the first natural products with a C-P-H bond and their involvement in the C-P-C bond formation. J Antibiot (Tokyo) (1983) 1.09
Epstein-Barr virus promotes epithelial cell growth in the absence of EBNA2 and LMP1 expression. J Virol (1999) 1.09
The C-terminal part of diacylglycerol kinase alpha lacking zinc fingers serves as a catalytic domain. Biochem J (1996) 1.09
Induction of senescence-like phenotypes by forced expression of hic-5, which encodes a novel LIM motif protein, in immortalized human fibroblasts. Mol Cell Biol (1997) 1.08
Extracellular glucans produced by oral streptococci. Arch Oral Biol (1976) 1.08
Comparison of beta-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig. Arzneimittelforschung (1974) 1.08
Sialyloligosaccharide chains of laminin as an extracellular matrix target for S fimbriae of Escherichia coli. Infect Immun (1993) 1.07
Studies on the biosynthesis of bialaphos (SF-1293). 1. Incorporation of 13C- and 2H-labeled precursors into bialaphos. J Antibiot (Tokyo) (1982) 1.07
Pseudopelade of Brocq. Dermatologica (1986) 1.06
Predictors of 5-year mortality in pulmonary Mycobacterium avium-intracellulare complex disease. Int J Tuberc Lung Dis (2012) 1.06
Osteoblast recruitment and bone formation enhanced by cell matrix-associated heparin-binding growth-associated molecule (HB-GAM). J Cell Biol (1998) 1.05
High affinity binding and overlapping localization of neurocan and phosphacan/protein-tyrosine phosphatase-zeta/beta with tenascin-R, amphoterin, and the heparin-binding growth-associated molecule. J Biol Chem (1998) 1.05
Studies on cell adhesion and recognition. III. The occurrence of alpha-mannosidase at the fibroblast cell surface, and its possible role in cell recognition. J Cell Biol (1981) 1.04
Four new rumen ciliates, Entodinium ogimotoi sp. n., E. bubalum sp.n., E. fujitai sp. n. and E. tsunodai sp. n. and Oligoisotricha bubali (Dogiel, 1928) n. comb. Nihon Juigaku Zasshi (1981) 1.04
[Alpha- and beta-adrenoceptor blocking actions of labetalol and effects on the myocardial function, coronary circulation and myocardial energy metabolism thereof (author's transl)]. Nihon Yakurigaku Zasshi (1978) 1.04
Isolation of sialyl oligosaccharides and sialyl oligosaccharide phosphates from bovine colostrum and human urine. Methods Enzymol (1987) 1.04
Large vertebral body, in addition to narrow spinal canal, are risk factors for cervical myelopathy. J Spinal Disord (1996) 1.03
Heparin-binding growth-associated molecule contains two heparin-binding beta -sheet domains that are homologous to the thrombospondin type I repeat. J Biol Chem (2000) 1.03
Lytic Epstein-Barr virus infection in the synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum (2000) 1.02
The role of heparin-binding growth-associated molecule (HB-GAM) in the postsynaptic induction in cultured muscle cells. J Neurosci (1995) 1.02
Molecular cloning of a diacylglycerol kinase isozyme predominantly expressed in human retina with a truncated and inactive enzyme expression in most other human cells. J Biol Chem (1994) 1.02
Comparative study on transduction and toxicity of protein transduction domains. Br J Pharmacol (2008) 1.02